Table 1 Inclusion and exclusion criteria for the prediction of CP by the GMA in late-preterm and term infants with NE
Inclusion criteria | Exclusion criteria | |
|---|---|---|
Participants | Studies with infants who were: - ≥ 34 0/7 wks GA - Diagnosis of NE - Had a GMA done between birth up to 6 months of life - had an assessment for CP by at least 2 years of age | Studies in which a diagnosis of CP was made after 2–3 years of age Studies with infants born with life-threatening congenital abnormalities, congenital viral infections, an abnormal karyotype, and metabolic disorders Animal studies |
Concept | GMA as a predictor of CP by 2 years of age is the main concept | |
Context | Studies that reported on: - Infants with NE managed and diagnosed by the standard of care (neurological history and examination) - Studies from all countries that have outcomes reported in the acute neonatal and in the follow-up period by 2 years of age - Studies in the English language only | Text and opinion papers were not considered for inclusion as this is a highly specific and medical topic |